The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Botiralieva G.K.

Ipsum Pathology LLC

Sharlai A.S.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Roshchin V.Yu.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology

Sidorov I.V.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Konovalov D.M.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology;
Russian Medical Academy of Continuous Professional Education

Rhabdomyosarcomas: structural distribution and analysis of an immunohistochemical profile

Authors:

Botiralieva G.K., Sharlai A.S., Roshchin V.Yu., Sidorov I.V., Konovalov D.M.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2020;82(5): 33‑41

DOI: 10.17116/patol20208205133

Read: 6320 times

Download PDF (RU)
Contact the author
Table of contents

RHABDOMYOSARCOMAS: STRUCTURAL DISTRIBUTION AND ANALYSIS OF AN IMMUNOHISTOCHEMICAL PROFILE
RHABDOMYOSARCOMAS: STRUCTURAL DISTRIBUTION AND ANALYSIS OF AN IMMUNOHISTOCHEMICAL PROFILE

To cite this article:

Botiralieva GK, Sharlai AS, Roshchin VYu, Sidorov IV, Konovalov DM. Rhabdomyosarcomas: structural distribution and analysis of an immunohistochemical profile. Russian Journal of Archive of Pathology. 2020;82(5):33‑41. (In Russ.)
https://doi.org/10.17116/patol20208205133

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Fluorescent in situ-hybridization (FISH) in onco­logy. P.A. Herzen Journal of Onco­logy. 2025;(6):88-93
Abstract:

Rhabdomyosarcoma (RMS) is a malignant soft tissue tumor originating from primitive mesenchymal cells, which is most common in children.

OBJECTIVE

To qualitatively and quantitatively assess the expression of myogenic transcription factors on a large sample, to identify potential phenotypic differences, and to estimate the distribution and frequency of aberrant markers, such as ALK, PAX5, WT1, PCK, CAM5.2, SIX1, and Synaptophysin.

MATERIAL AND METHODS

The investigation included 202 tumor tissue samples. Five tissue microarrays were assembled from the obtained material for subsequent histological and immunohistochemical studies.

RESULTS

Embryonal RMS (ERMS) was diagnosed in 103 cases; alveolar RMS (ARMS) was detected in 80; spindle-cell/sclerosing RMS (SRMS) was found in 16 cases; epithelioid RMS (EpiRMS) was diagnosed in 2 patients. The expression of Myogenin and MyoD1 was detected in all the examined RMS tissue samples. ARMS was more characterized by staining at 1+ and 2+ intensities; at the same time, more than 50% of ERMS, SRMS, and EpiRMS cases showed staining at 1+ intensity. ALK expression was investigated using the D5F3 and p80 clones. The D5F3 clone displayed a higher staining intensity than the p80 clone (p<0.05). The expression of PAX5 was observed in 13 of 75 ARMS cases. That of WT1 and SIX1 was found in all RMS groups.

CONCLUSION

The morphological diagnosis of RMS requires a careful assessment of all of the above factors, especially taking into account the variability in the expression of myogenic transcription factors and the high level of phenotypic aberration.

Keywords:

rhabdomyosarcoma
immunohistochemical profile
ALK
myogenin
MyoD1

Authors:

Botiralieva G.K.

Ipsum Pathology LLC

Sharlai A.S.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Roshchin V.Yu.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, and Immunology

Sidorov I.V.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Konovalov D.M.

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology;
Russian Medical Academy of Continuous Professional Education

Received:

06.03.2020

Accepted:

16.06.2020

Close metadata

References:

  1. O’Shea PA. Myogenic tumors of soft tissue. In: Coffin CM, Dehner LP, eds. Pediatric soft tissue tumors. Baltimore: Williams & Wilkins; 1997.
  2. Harms D. Soft tissue sarcomas in the Kiel Pediatric Tumor Registry. Curr Top Pathol. 1995;89:31-45.  https://doi.org/10.1007/978-3-642-77289-4_3
  3. Parham DM, Barr FG. Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol. 2013;20(6):387-397.  https://doi.org/10.1097/PAP.0b013e3182a92d0d
  4. Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol. 2001;14(5): 506-514.  https://doi.org/10.1038/modpathol.3880437
  5. Weiss SW, Goldblum JR. General considerations. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss’s soft tissue tumors. St Louis: Mosby; 2001.
  6. Jo VY, Mariño-Enríquez A, Fletcher CD. Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma. Am J Surg Pathol. 2011;35(10):1523-1530. https://doi.org/10.1097/PAS.0b013e31822e0907
  7. Zin A, Bertorelle R, Dall’Igna P, Manzitti C, Gambini C, Bisogno G, Rosolen A, Alaggio R. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study. J Pediatr Hematol.Oncol. 2014;36(4):E256. https://doi.org/10.1097/PAS.0000000000000105
  8. Agaram NP, Zhang L, Sung YS, Cavalcanti MS, Torrence D, Wexler L, Francis G, Sommerville S, Swanson D, Dickson BC, Suurmeijer AJH, Williamson R, Antonescu CR. Expanding the spectrum of intraosseous rhabdomyosarcoma: correlation between 2 distinct gene fusions and phenotype. Am J Surg Pathol. 2019;43(5):695-702.  https://doi.org/10.1097/PAS.0000000000001227
  9. Leiner J, Loarer F. The current landscape of rhabdomyosarcomas: an update. Virchows Arch. 2019;476(1):97-108.  https://doi.org/10.1007/s00428-019-02676-9
  10. Eusebi V, Rilke F, Ceccarelli C, Fedeli F, Schiaffino S, Bussolati G. Fetal heavy chain skeletal myosin: an oncofetal antigen expressed by rhabdomyosarcoma. Am J Surg Pathol. 1986;10(10):680-686.  https://doi.org/10.1097/00000478-198610000-00003
  11. Parham DM, Webber B, Holt H, Williams WK, Maurer H. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms: result of an Intergroup Rhabdomyosarcoma study project. Cancer. 1991;67(12):3072-3080. https://doi.org/10.1002/1097-0142(19910615)67:12<3072::aid-cncr2820671223>3.0.co;2-z "> 3.0.co;2-z" target="_blank">https://doi.org/10.1002/1097-0142(19910615)67:12<3072::aid-cncr2820671223>3.0.co;2-z
  12. Folpe AL. MyoD1 and myogenin expression in human neoplasia: a review and update. Adv Anat Pathol. 2002;9(3):198-203.  https://doi.org/10.1097/00125480-200205000-00003
  13. Crawford Parks TE, Marcellus KA, Langill J, Ravel-Chapuis A, Michaud J, Cowan KN, Côté J, Jasmin BJ. Novel roles for staufen1 in embryonal and alveolar rhabdomyosarcoma via c-myc-dependent and -independent events. Sci Rep. 2017;7:42342. https://doi.org/10.1038/srep42342
  14. Yoshida A, Shibata T, Wakai S, Ushiku T, Tsuta K, Fukayama M, Makimoto A, Furuta K, Tsuda H. Anaplastic lymphoma kinase status in rhabdomyosarcomas. Mod Pathol. 2013;26(6):772-781.  https://doi.org/10.1038/modpathol.2012.222
  15. Morgenstern DA, Gibson S, Sebire NJ, Anderson J. PAX5 expression in rhabdomyosarcoma. Am J Surg Pathol. 2009;33(10):1575-1577. https://doi.org/10.1097/PAS.0b013e3181abe137
  16. Carpentieri D, Nichols K, Chou P, Matthews M, Pawel B, Huff D. The Expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol. 2002;15(10):1080-1086. https://doi.org/10.1097/01.MP.0000028646.03760.68
  17. Bahrami A, Gown A, Baird GS, Hicks MJ, Folpe AL. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol. 2008;21(7):795-806.  https://doi.org/10.1038/modpathol.2008.86
  18. Hosoi H, Sugimoto T, Hayashi Y, Inaba T, Horii Y, Morioka H, Fushiki S, Hamazaki M, Sawada T. Differential expression of myogenic regulatory genes, MyoD1 and myogenin, in human rhabdomyosarcoma sublines. Int J Cancer. 1992;50(6):977-983.  https://doi.org/10.1002/ijc.2910500626
  19. Dias P, Chen B, Dilday B, Palmer H, Hosoi H, Singh S, Wu C, Li X, Thompson J, Parham D, Qualman S, Houghton P. Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass. Am J Pathol. 2000;156(2):399-408.  https://doi.org/10.1016/S0002-9440(10)64743-8
  20. Sebire NJ, Gibson S, Rampling D, Williams S, Malone M, Ramsay AD. Immunohistochemical findings in embryonal small round cell tumors with molecular diagnostic confirmation. Appl Immunohistochem Mol Morphol. 2005;13(1):1-5.  https://doi.org/10.1097/00129039-200503000-00001
  21. Sullivan LM, Atkins KA, LeGallo RD. PAX immunoreactivity identifies alveolar rhabdomyosarcoma. Am J Surg Pathol. 2009;33(5): 775-780.  https://doi.org/10.1097/PAS.0b013e318191614f
  22. Kim A, Park EY, Kim K, Lee JH, Shin DH, Kim JY, Park DY, Lee CH, Sol MY, Choi KU, Kim JI, Lee IS. Prognostic significance of WT1 expression in soft tissue sarcoma. World J Surg Oncol. 2014;12:214.  https://doi.org/10.1186/1477-7819-12-214
  23. Carpentieri DF, Nichols K, Chou PM, Matthews M, Pawel B, Huff D. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol. 2002;15(10):1080-1086. https://doi.org/10.1097/01.MP.0000028646.03760.6B
  24. Wu W, Huang R, Wu Q, Li P, Chen J, Li B, Liu H. The role of Six1 in the genesis of muscle cell and skeletal muscle development. Int J Biol Sci. 2014;10(9):983-989.  https://doi.org/10.7150/ijbs.9442
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.